查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1414447

2024 年神经调节全球市场报告

Neuromodulation Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，神经调节的市场规模迅速扩大。将从2023年的64.3亿美元成长到2024年的71.4亿美元，复合年增长率为11.1%。神经调节场的表现很大程度取决于几个因素。慢性病的盛行率不断上升，支持神经调节治疗的临床证据和研究不断积累，患者对非侵入性治疗方案的需求不断增长，以及支持这些进展的政府倡议和资金；这些包括扩大这些治疗方法的适应症，以及领域内的合作和伙伴关係促进创新和发展的产业。

神经调节市场规模预计在未来几年将快速成长。 2028年将以10.5%的年复合成长率（CAGR）成长至106.4亿美元。许多因素与预期的增长有关，特别是设备的小型化、对老龄化人口中普遍存在的神经系统疾病的日益关注、精神病学应用的增加、以患者为中心的治疗方法以及健康方面的例子包括扩大全球护理的覆盖范围。

神经系统疾病的盛行率不断上升是推动神经调节市场成长的关键因素。这些疾病包括影响大脑、神经和脊髓的各种问题。神经调节干预措施为管理和调节各种神经系统疾病（包括阿兹海默症、帕金森氏症和癫痫）提供了一条有前途的途径。欧洲脑理事会2022年4月举行的报告报告称，全球整体有600多种神经系统疾病和近300种精神疾病，其中包括阿兹海默症和其他失智症，人数已达5,000万人。癫痫症影响全球 6500 万人，凸显了神经系统疾病的重大影响。预计到 2050 年，欧洲失智症患者人数将从 1,050 万大幅增加至 1,870 万，这使得神经调节对于解决这些日益严重的健康问题至关重要。事实表明，它发挥了作用。

医疗保健支出的增加将推动神经调节市场的成长。医疗保健支出包括各种与健康相关的活动的支出，例如服务、保险、研究和公共卫生倡议。医疗保健支出的增加推动了神经系统疾病创新治疗方法和诊断的进步和采用。强大的财政资源也支持对新技术的广泛研究，以提高其有效性、安全性和准确性。值得注意的是，英国国家统计局报告称，从 2020 年到 2021 年，英国医疗保健支出名目增加 9.4%，实际成长 9.7%。此外，2021年预防性医疗保健支出激增至457.2亿美元，比前一年增长了一倍多，这表明对神经调节市场的成长做出了重大贡献。

2023 年神经调节市场最大的地区是北美。神经调节市场报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与抑制因素
    • 市场驱动因素
    • 市场抑制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球神经调节市场，依技术细分、实际和预测，2018-2023、2023-2028、2033
  • 内部神经调节
  • 体外神经调节（非侵入性）
  • 全球神经调节市场，依生物材料细分，实际与预测，2018-2023、2023-2028、2033
  • 高分子生物材料
  • 金属生物材料
  • 陶瓷生物材料
  • 全球神经调节市场，依应用、实际及预测细分，2018-2023、2023-2028、2033
  • 慢性疼痛
  • 尿失禁和大便失禁
  • 偏头痛
  • 故障恢復综合症
  • 帕金森氏症
  • 癫痫
  • 发抖
  • 忧郁症
  • 其他用途
  • 全球神经调节市场，按最终用户细分，实际和预测，2018-2023、2023-2028、2033
  • 医院
  • 诊所
  • 家庭保健

第 7 章 区域与国家分析

  • 全球神经调节市场，按地区、实际和预测，2018-2023、2023-2028、2033
  • 全球神经调节市场，按国家、实际和预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 神经调节市场的竞争形势
  • 神经调节市场公司概况
    • Abbott Laboratories
    • Soterix Medical Inc.
    • Boston Scientific Corporation
    • Medtronic plc
    • Synapse Biomedical Inc.

第31章竞争基准化分析

第 32 章竞争对手仪表板

第三十三章 重大併购

第34章 未来前景与可能性分析

第35章附录

简介目录
Product Code: r11957

“Neuromodulation Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neuromodulation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neuromodulation? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The neuromodulation market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Technology: Internal Neuromodulation; External Neuromodulation (Non-invasive)
  • 2) By Biomaterial: Polymeric Biomaterial; Metallic Biomaterial; Ceramic Biomaterial
  • 3) By Application: Chronic Pain; Urinary And Fecal Incontinence; Migraine; Failed Back Syndrome; Parkinson Disease; Epilepsy; Tremor; Depression; Other Applications
  • 4) By End-User: Hospitals; Clinics; Home Healthcare
  • Companies Mentioned: Abbott Laboratories; Soterix Medical Inc.; Boston Scientific Corporation; Medtronic plc; Synapse Biomedical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Neuromodulation refers to the adjustment of nerve activity through electrical or pharmacological means, directly targeting specific areas. It's a reversible method employed to alleviate pain.

The primary technologies in neuromodulation include internal and external methods. Internal neuromodulation involves implanting an electrode near a targeted nerve and administering a low-voltage electric current. Biomaterials used encompass polymeric, metallic, and ceramic materials. These technologies are applied in treating various conditions such as chronic pain, urinary and fecal incontinence, migraine, failed back syndrome, Parkinson's disease, epilepsy, tremor, depression, and more. They find use across multiple settings including hospitals, clinics, and home healthcare environments.

The neuromodulation market research report is one of a series of new reports from The Business Research Company that provides neuromodulation market statistics, including the neuromodulation industry's global market size, regional shares, competitors with a neuromodulation market share, detailed neuromodulation market segments, market trends, and opportunities, and any further data you may need to thrive in the neuromodulation industry. This neuromodulation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuromodulation market size has grown rapidly in recent years. It will grow from $6.43 billion in 2023 to $7.14 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. Historical growth in the field of neuromodulation can be largely attributed to several factors. These include the increasing prevalence of chronic disorders, the accumulation of clinical evidence and research supporting neuromodulation therapies, a growing demand from patients for non-invasive treatment options, government initiatives and funding supporting these advancements, the widening scope of indications for these therapies, as well as collaborations and partnerships within the industry that fostered innovation and development.

The neuromodulation market size is expected to see rapid growth in the next few years. It will grow to $10.64 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. Anticipated growth in the upcoming period is linked to various factors, notably the miniaturization of devices, a heightened focus on neurological disorders prevalent in the aging population, increased applications in psychiatry, patient-centric approaches in treatment, and the global expansion of healthcare access.

The increasing prevalence of neurological disorders stands as a significant driver for the growth of the neuromodulation market. These disorders encompass a wide range of issues affecting the brain, nerves, and spinal cord. Neuromodulation interventions offer promising avenues for managing and regulating various neurological conditions, including Alzheimer's, Parkinson's, and epilepsy. Reports from the European Brain Council in April 2022 highlighted over 600 neurological diseases and nearly 300 psychiatric conditions globally, with 50 million individuals affected by Alzheimer's and other dementias. Epilepsy, affecting 65 million people worldwide, underscores the substantial impact of neurological disorders. Projections indicate a substantial rise in dementia cases in Europe, from 10.5 million to 18.7 million by 2050, signifying the pivotal role of neuromodulation in addressing these escalating health concerns.

The upward trajectory of healthcare expenditures is poised to drive the growth of the neuromodulation market. Healthcare expenditure encompasses spending on various health-related activities, including services, insurance, research, and public health initiatives. Increased healthcare spending facilitates the advancement and adoption of innovative therapies and diagnostic methods for neurological disorders. Enhanced financial resources also support extensive research into novel neuromodulation technologies, enhancing their effectiveness, safety, and precision. Notably, the Office for National Statistics reported a 9.4% nominal increase and a 9.7% real-term rise in healthcare spending in the UK between 2020 and 2021. Moreover, preventive care spending surged to $45.72 billion in 2021, more than doubling from the previous year, indicating a significant contribution to the growth of the neuromodulation market.

Technological advancements emerge as a pivotal trend shaping the neuromodulation market. Major players in this sector are dedicated to pioneering innovative technological solutions to fortify their market positions. For instance, Abbott's December 2022 launch of the Eterna spinal cord stimulation (SCS) system, featuring the smallest implantable, rechargeable spinal cord stimulator, illustrates the pursuit of advancements. Incorporating patented low-dose BurstDR stimulation, this system demonstrates superior pain relief compared to conventional approaches. Additionally, Abbott's NeuroSphere Virtual Clinic, launched in March 2021, represents a pioneering technology allowing remote patient-clinician interactions for optimizing treatment settings and exploring new therapeutic options. Approved by the US FDA, this initiative broadens access to effective treatment for chronic pain or Parkinson's disease, particularly beneficial during circumstances such as the COVID-19 pandemic.

Major players in the neuromodulation market are focusing on introducing next-generation devices with advanced features, such as the implantable pulse generator (IPG), to gain a competitive edge. For example, CVRx's November 2022 launch of the Barostim Neo2 IPG, an upgraded version of its neuromodulation device for heart failure treatment, exemplifies this pursuit. With improved efficiency, reduced size, and enhanced design facilitating easier implantation, the Barostim Neo2 retains the clinically proven Barostim therapy, emphasizing the drive towards patient-friendly, durable, and efficient solutions in neuromodulation.

In March 2022, Electromedical Products International Inc (EPI), a prominent US-based medical device manufacturer, completed the acquisition of Pulvinar Neuro LLC for an undisclosed sum. This strategic acquisition empowers EPI to further its progress in advancing patented technologies, notably transcranial alternating current stimulation (tACS), enhancing personalized feedback stimulation, and expanding its cloud-enabled digital therapeutics for psychiatric and neurological conditions. Pulvinar Neuro, a US-based neurotechnology company, specializes in leveraging cutting-edge technologies to support neuroscience research, aligning seamlessly with EPI's objectives in advancing medical innovation in this domain.

Major companies operating in the neuromodulation market report are Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, Neuropace Inc., LivaNova PLC, Neurosigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, ReShape Lifesciences Inc., Inspire Medical Systems Inc., Bioventus LLC, Saluda Medical Pty Ltd., Otolith Labs Inc., Machine Medicine Inc., Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuronoff ApS, Neuros Medical Inc., Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., Magic Leap Inc., Omron Corporation

North America was the largest region in the neuromodulation market in 2023. The regions covered in the neuromodulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the neuromodulation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The neuromodulation market includes revenues earned by entities through sacral nerve stimulation for pelvic disorders and incontinence, deep brain stimulation (DBS) treatment for Parkinson's disease, and spinal cord stimulation for ischemic disorders (angina, peripheral vascular disease). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Neuromodulation Market Characteristics

3. Neuromodulation Market Trends And Strategies

4. Neuromodulation Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Neuromodulation Market Size and Growth

  • 5.1. Global Neuromodulation Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Neuromodulation Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Neuromodulation Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Neuromodulation Market Segmentation

  • 6.1. Global Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Internal Neuromodulation
  • External Neuromodulation (Non-invasive)
  • 6.2. Global Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Polymeric Biomaterial
  • Metallic Biomaterial
  • Ceramic Biomaterial
  • 6.3. Global Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Chronic Pain
  • Urinary And Fecal Incontinence
  • Migraine
  • Failed Back Syndrome
  • Parkinson Disease
  • Epilepsy
  • Tremor
  • Depression
  • Other Applications
  • 6.4. Global Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Home Healthcare

7. Neuromodulation Market Regional And Country Analysis

  • 7.1. Global Neuromodulation Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Neuromodulation Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Neuromodulation Market

  • 8.1. Asia-Pacific Neuromodulation Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Neuromodulation Market

  • 9.1. China Neuromodulation Market Overview
  • 9.2. China Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Neuromodulation Market

  • 10.1. India Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Neuromodulation Market

  • 11.1. Japan Neuromodulation Market Overview
  • 11.2. Japan Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Neuromodulation Market

  • 12.1. Australia Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Neuromodulation Market

  • 13.1. Indonesia Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Neuromodulation Market

  • 14.1. South Korea Neuromodulation Market Overview
  • 14.2. South Korea Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Neuromodulation Market

  • 15.1. Western Europe Neuromodulation Market Overview
  • 15.2. Western Europe Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Neuromodulation Market

  • 16.1. UK Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Neuromodulation Market

  • 17.1. Germany Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Neuromodulation Market

  • 18.1. France Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Neuromodulation Market

  • 19.1. Italy Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Neuromodulation Market

  • 20.1. Spain Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Neuromodulation Market

  • 21.1. Eastern Europe Neuromodulation Market Overview
  • 21.2. Eastern Europe Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Neuromodulation Market

  • 22.1. Russia Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Neuromodulation Market

  • 23.1. North America Neuromodulation Market Overview
  • 23.2. North America Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Neuromodulation Market

  • 24.1. USA Neuromodulation Market Overview
  • 24.2. USA Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Neuromodulation Market

  • 25.1. Canada Neuromodulation Market Overview
  • 25.2. Canada Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Neuromodulation Market

  • 26.1. South America Neuromodulation Market Overview
  • 26.2. South America Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Neuromodulation Market

  • 27.1. Brazil Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Neuromodulation Market

  • 28.1. Middle East Neuromodulation Market Overview
  • 28.2. Middle East Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Neuromodulation Market

  • 29.1. Africa Neuromodulation Market Overview
  • 29.2. Africa Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Neuromodulation Market Competitive Landscape And Company Profiles

  • 30.1. Neuromodulation Market Competitive Landscape
  • 30.2. Neuromodulation Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Soterix Medical Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Boston Scientific Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Medtronic plc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Synapse Biomedical Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Neuromodulation Market Competitive Benchmarking

32. Global Neuromodulation Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Neuromodulation Market

34. Neuromodulation Market Future Outlook and Potential Analysis

  • 34.1 Neuromodulation Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Neuromodulation Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Neuromodulation Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer